GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Net Margin %

3SBio, (FRA:YFK) Net Margin % : 28.53% (As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. 3SBio,'s Net Income for the six months ended in Dec. 2016 was €58.3 Mil. 3SBio,'s Revenue for the six months ended in Dec. 2016 was €204.5 Mil. Therefore, 3SBio,'s net margin for the quarter that ended in Dec. 2016 was 28.53%.

The historical rank and industry rank for 3SBio,'s Net Margin % or its related term are showing as below:

FRA:YFK' s Net Margin % Range Over the Past 10 Years
Min: 15.28   Med: 24.67   Max: 45.24
Current: 25.39


FRA:YFK's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -162.58 vs FRA:YFK: 25.39

3SBio, Net Margin % Historical Data

The historical data trend for 3SBio,'s Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Net Margin % Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.05 15.28 25.80 31.46 25.47

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.17 30.68 32.15 21.98 28.53

Competitive Comparison of 3SBio,'s Net Margin %

For the Biotechnology subindustry, 3SBio,'s Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Net Margin % distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Net Margin % falls into.



3SBio, Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

3SBio,'s Net Margin for the fiscal year that ended in Dec. 2016 is calculated as

Net Margin=Net Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=97.62/383.223
=25.47 %

3SBio,'s Net Margin for the quarter that ended in Dec. 2016 is calculated as

Net Margin=Net Income (Q: Dec. 2016 )/Revenue (Q: Dec. 2016 )
=58.322/204.459
=28.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio,  (FRA:YFK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


3SBio, Net Margin % Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines